Td Asset Management Inc Acadia Pharmaceuticals Inc Put Options Transaction History
Td Asset Management Inc
- $102 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding ACAD
# of Institutions
337Shares Held
168MCall Options Held
765KPut Options Held
260K-
Baker Bros. Advisors LP New York, NY42.9MShares$649 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$230 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$183 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$132 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$110 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.45B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...